JulietteMacé

Associate

Paris + 33.1.56.59.38.12

Juliette Macé practices in the areas of private and public M&A and securities law. She advises French and foreign clients on domestic and cross-border transactions, joint ventures, capital markets, and corporate law matters.

Prior to joining Jones Day, Juliette completed several internships at French and international law firms. She also gained valuable experience as an M&A broker in London where she advised major investment funds on the implementation of warranty and indemnity (W&I) insurance.

Experience

  • Sanofi sells anti-inflammatory drugs to Fidia FarmaceuticiJones Day advised Sanofi in the sale of a portfolio of pharmaceutical products to Fidia Farmaceutici.
  • Framatome acquires ValinoxJones Day advised Framatome SAS in the acquisition of 100% of the shares of Valinox Nucléaire SAS, a French company specializing in the production of seamless tubes for nuclear use, from the Vallourec group.
  • EDAP completes follow-on offering of American Depositary SharesJones Day represented EDAP TMS, a global leader in robotic energy-based therapies, in connection with its follow-on offering of 4,150,000 American Depositary Shares (ADSs) on the Nasdaq Global Market.
  • H.C. Wainwright underwrites Nasdaq IPO by Biophytis, including issuance of 1.2 million American Depositary SharesJones Day advised H.C. Wainwright, as underwriter, in connection with the Nasdaq IPO by Biophytis S.A., a French Euronext Growth-listed biotech company, including the issuance of 1.2 million American Depositary Shares (ADSs).
  • DataBank acquires zColo for $1.4 billionJones Day advised DataBank, a leading provider of enterprise-class colocation, connectivity, and managed services, in connection with the acquisition and financing of zColo, including certain U.S. and European data center assets, from Zayo Group Holdings, Inc. for $1.4 billion.